Compagnie Lombard Odier SCmA’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54K | Hold |
410
| – | – | ﹤0.01% | 397 |
|
|
2025
Q1 | $3.55K | Hold |
410
| – | – | ﹤0.01% | 443 |
|
|
2024
Q4 | $1.99K | Hold |
410
| – | – | ﹤0.01% | 426 |
|
|
2024
Q3 | $3.17K | Hold |
410
| – | – | ﹤0.01% | 429 |
|
|
2024
Q2 | $4.1K | Hold |
410
| – | – | ﹤0.01% | 410 |
|
|
2024
Q1 | $4.98K | Hold |
410
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $5.87K | Hold |
410
| – | – | ﹤0.01% | 506 |
|
|
2023
Q3 | $3.19K | Hold |
410
| – | – | ﹤0.01% | 552 |
|
|
2023
Q2 | $5.86K | Hold |
410
| – | – | ﹤0.01% | 524 |
|
|
2023
Q1 | $6K | Hold |
410
| – | – | ﹤0.01% | 569 |
|
|
2022
Q4 | $7K | Hold |
410
| – | – | ﹤0.01% | 623 |
|
|
2022
Q3 | $6K | Hold |
410
| – | – | ﹤0.01% | 583 |
|
|
2022
Q2 | $11K | Hold |
410
| – | – | ﹤0.01% | 534 |
|
|
2022
Q1 | $15K | Buy |
+410
| New | +$15K | ﹤0.01% | 531 |
|